CCL
67
-4
GOOGL
56
3
MMC
48
-5
AVGO
38
-16
PGR
33
-4
MDT
52
2
STI
27
-2
EFX
49
-6
MTCH
55
-7
ADM
59
12
MET
48
-2
BXP
62
2
MSFT
62
9
ALLE
39
-27
SWKS
51
-4
FIS
50
-5
ADSK
53
9
DE
59
-3
PVH
34
-3
MAT
43
-3
CCL
67
-4
GOOGL
56
3
MMC
48
-5
AVGO
38
-16
PGR
33
-4
MDT
52
2
STI
27
-2
EFX
49
-6
MTCH
55
-7
ADM
59
12
MET
48
-2
BXP
62
2
MSFT
62
9
ALLE
39
-27
SWKS
51
-4
FIS
50
-5
ADSK
53
9
DE
59
-3
PVH
34
-3
MAT
43
-3
Financhill
Back

Kiniksa Pharmaceuticals International PLC Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Buy
63

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
$28.09
Seasonality Move:
4.42%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Kiniksa Pharmaceuticals International PLC Stock Forecast

  • Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 16.1% based on the past 7 years of stock performance.
  • Kiniksa Pharmaceuticals International PLC has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Kiniksa Pharmaceuticals International PLC Stock Undervalued?
    The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $28.09. The Score for KNSA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • KNSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Kiniksa Pharmaceuticals International PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 16.1% based on the past 7 years of stock performance.

Kiniksa Pharmaceuticals International PLC Stock Rating

Buy
63
Kiniksa Pharmaceuticals International PLC (KNSA) is a Buy

Is Kiniksa Pharmaceuticals International PLC overpriced?

  • Kiniksa Pharmaceuticals International PLC has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Kiniksa Pharmaceuticals International PLC Stock Price History

Is KNSA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kiniksa.com

52-Week Data

52-Week High:
30.69
52-Week Low:
17.82

Prediction Charts

Market Cap:
2B
Price in USD:
28.09
Volume:
355.3K
Beta:
0.02

Technical Analysis

SMA50:
27.71
SMA100:
24.49
SMA200:
23.27
52-Wk Change:
30.05%

Stock Predictions

  • Is Kiniksa Pharmaceuticals International PLC stock public?
    Yes, Kiniksa Pharmaceuticals International PLC is a publicly traded company.
  • What is the Kiniksa Pharmaceuticals International PLC stock quote today?
    The Kiniksa Pharmaceuticals International PLC stock price is 28.09 USD today.
  • How to buy Kiniksa Pharmaceuticals International PLC stock online?
    You can buy Kiniksa Pharmaceuticals International PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-23 28.61 28.72 29.29 28.25
Jun-24 28.92 29.06 29.20 28.48
Jun-25 28.91 28.38 29.23 28.22
Jun-26 28.64 28.49 28.71 27.94
Jun-27 28.50 28.04 28.86 27.91
Jun-30 28.51 27.67 28.54 27.08
Jul-1 27.55 27.24 27.90 27.24
Jul-2 27.25 27.44 27.97 26.89
Jul-3 27.50 27.88 27.92 27.12
Jul-7 27.58 27.95 28.17 27.30
Jul-8 27.76 27.21 28.16 27.06
Jul-9 27.71 28.80 29.25 27.50
Jul-10 28.77 28.95 29.09 28.50
Jul-11 28.74 28.09 28.74 27.92

Kiniksa Pharmaceuticals International PLC Earnings

Kiniksa Pharmaceuticals International PLC Earnings Report: Per Share Kiniksa Pharmaceuticals International PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kiniksa Pharmaceuticals International PLC Forecast Revenue Growth

Kiniksa Pharmaceuticals International PLC Stock Analysis: Historical quarterly revenues per share for Kiniksa Pharmaceuticals International PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.10 per share, an increase this year of $1.15 per share, and an increase next year of $0.57 per share.

* Kiniksa Pharmaceuticals International PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.